Sfmg, LLC Amgen Inc Transaction History

Sfmg, LLC

$1.14 Billion
Q2 2024

A detailed history of Sfmg, LLC transactions in Amgen Inc stock. As of the latest transaction made, Sfmg, LLC holds 2,346 shares of AMGN stock, worth $756,983. This represents 0.06% of its overall portfolio holdings.

Number of Shares

2,346

Previous 2,450 4.24%

Holding current value

$756,983

Previous $696,000 5.32%

% of portfolio

0.06%

Previous 0.06%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $27,326 - $33,208	-104 Reduced 4.24%	2,346 $733,000
Q1 2024 May 07, 2024	SELL	$268.87 - $324.56 $28,500 - $34,403	-106 Reduced 4.15%	2,450 $696,000
Q4 2023 Jan 30, 2024	BUY	$255.7 - $288.46 $3,068 - $3,461	12 Added 0.47%	2,556 $736,000
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $10,057 - $12,487	46 Added 1.84%	2,544 $683,000
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $87,422 - $103,374	-408 Reduced 14.04%	2,498 $554,000
Q1 2023 May 01, 2023	BUY	$225.79 - $275.2 $74,736 - $91,091	331 Added 12.85%	2,906 $702,000
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $687 - $873	3 Added 0.12%	2,575 $0
Q3 2022 Oct 20, 2022	BUY	$224.46 - $253.15 $5,835 - $6,581	26 Added 1.02%	2,572 $634,000
Q2 2022 Aug 08, 2022	SELL	$230.71 - $256.74 $5,306 - $5,905	-23 Reduced 0.9%	2,546 $619,000
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $53,063 - $58,701	-242 Reduced 8.61%	2,569 $621,000
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $21,280 - $24,353	107 Added 3.96%	2,811 $632,000
Q3 2021 Nov 01, 2021	BUY	$212.27 - $248.7 $42,666 - $49,988	201 Added 8.03%	2,704 $575,000
Q2 2021 Aug 06, 2021	SELL	$233.58 - $259.14 $97,402 - $108,061	-417 Reduced 14.28%	2,503 $610,000
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $4,438 - $5,172	20 Added 0.69%	2,920 $727,000
Q4 2020 Feb 02, 2021	BUY	$216.38 - $257.67 $109,271 - $130,123	505 Added 21.09%	2,900 $667,000
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $91,783 - $112,631	464 Added 24.03%	2,395 $565,000
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $5,297 - $6,809	-28 Reduced 1.43%	1,931 $466,000
Q2 2019 Aug 05, 2019	SELL	$166.7 - $195.41 $666 - $781	-4 Reduced 0.2%	1,959 $343,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $3,617 - $4,077	-20 Reduced 1.01%	1,963 $373,000
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $75,284 - $87,881	422 Added 27.03%	1,983 $386,000
Q3 2018 Nov 15, 2018	SELL	$185.29 - $208.89 $1.07 Million - $1.2 Million	-5,765 Reduced 78.69%	1,561 $292,000
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $78,873 - $88,592	-475 Reduced 6.09%	7,326 $1.35 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $53,878 - $62,964	-318 Reduced 3.92%	7,801 $1.33 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $58,232 - $65,063	-345 Reduced 4.08%	8,119 $1.41 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $1.42 Million - $1.62 Million	8,464	8,464 $1.58 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sfmg, LLC with notifications on news.

Account